AIS Healthcare is a healthcare group which is committed to advancing quality in patient care. They own and operates a series of pharmacies and skilled nursing facilities. Furthermore, AIS Healthcare is committed to quality patient care through Targeted Drug Delivery systems.
The founder of AIS Healthcare is Chuck Bell, Jr., whom is currently the President of the company. He began his career in infusion services in 1992. He holds two degrees, a Bachelor of Science in Pharmacy and a PharmD degree and has 20 years of Pharmacy experience. Simon Castellanos serves as the CEO of the company, whom worked previously at Fresenius Kabi healthcare and has a wide range of experience in finance and operations.
The targeted drug delivery system is what truly sets the company apart. They apply a mix between subcutaneous and intravenous delivery. They have a Targeted Drug Delivery method which operates from their two state-of-the-art compounding pharmacies that ship 550 prescriptions per day. They assure their patients of 1:1,000,000 sterility levels and test all of their products with third party labs.
The company’s Advanced Infusion Care teams have a 99% satisfaction rate. They have a skilled nursing staff which is available to administer their infusion care product in a home setting. Their nurses are certified in intravenous and subcutaneous delivery of medication, and their staff are led by experienced professionals.
Their team is recognized and accredited by ACHC, the Accreditation Commission For Healthcare to go beyond the standard required for healthcare accreditation. Finally, their FDA inspections have resulted in 0 form 483 observations at the time of their last inspection.